share_log

凯普生物(300639.SZ):前三季度净亏损2.62亿元

Guangdong Hybribio Biotech (300639.SZ): The net loss in the first three quarters was 0.262 billion yuan.

Gelonghui Finance ·  Oct 29, 2024 20:38

Guangdong Hybribio Biotech (300639.SZ) released the third quarter report for 2024 on October 29th. In the first three quarters of 2024, the company achieved revenue of 0.61 billion yuan, a decrease of 28.26% year-on-year; the net income attributable to shareholders of the listed company was a loss of 0.262 billion yuan, a decrease of 252.19% year-on-year; the net income after deducting non-recurring gains and losses was a loss of 0.27 billion yuan, a decrease of 276.98% year-on-year; the basic earnings per share was -0.4068 yuan per share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment